Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-102967
Filing Date
2025-08-05
Accepted
2025-08-05 16:01:03
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20250630.htm   iXBRL 10-Q 2180062
2 EX-10.1 idya-ex10_1.htm EX-10.1 31812
3 EX-10.2 idya-ex10_2.htm EX-10.2 145835
4 EX-10.3 idya-ex10_3.htm EX-10.3 7545
5 EX-31.1 idya-ex31_1.htm EX-31.1 17726
6 EX-31.2 idya-ex31_2.htm EX-31.2 17667
7 EX-32.1 idya-ex32_1.htm EX-32.1 15631
  Complete submission text file 0000950170-25-102967.txt   9290652

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20250630.xsd EX-101.SCH 1254974
73 EXTRACTED XBRL INSTANCE DOCUMENT idya-20250630_htm.xml XML 1673352
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 251184719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)